8-6873067-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005218.4(DEFB1):c.62-2241C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.823 in 152,222 control chromosomes in the GnomAD database, including 51,808 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.82 ( 51808 hom., cov: 34)
Consequence
DEFB1
NM_005218.4 intron
NM_005218.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.617
Publications
1 publications found
Genes affected
DEFB1 (HGNC:2766): (defensin beta 1) Defensins form a family of microbicidal and cytotoxic peptides made by neutrophils. Members of the defensin family are highly similar in protein sequence. This gene encodes defensin, beta 1, an antimicrobial peptide implicated in the resistance of epithelial surfaces to microbial colonization. This gene maps in close proximity to defensin family member, defensin, alpha 1 and has been implicated in the pathogenesis of cystic fibrosis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.882 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.823 AC: 125227AN: 152104Hom.: 51771 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
125227
AN:
152104
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.823 AC: 125329AN: 152222Hom.: 51808 Cov.: 34 AF XY: 0.823 AC XY: 61225AN XY: 74428 show subpopulations
GnomAD4 genome
AF:
AC:
125329
AN:
152222
Hom.:
Cov.:
34
AF XY:
AC XY:
61225
AN XY:
74428
show subpopulations
African (AFR)
AF:
AC:
36946
AN:
41538
American (AMR)
AF:
AC:
11674
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
2830
AN:
3472
East Asian (EAS)
AF:
AC:
4584
AN:
5190
South Asian (SAS)
AF:
AC:
4130
AN:
4826
European-Finnish (FIN)
AF:
AC:
8238
AN:
10584
Middle Eastern (MID)
AF:
AC:
262
AN:
294
European-Non Finnish (NFE)
AF:
AC:
54235
AN:
67998
Other (OTH)
AF:
AC:
1768
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1145
2290
3436
4581
5726
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
886
1772
2658
3544
4430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2887
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.